Profil société Oncodesign PM, activité, actionnaires et dirigeants de l'entreprise ALOPM - FR001400CM63 - Boursier.com

France

OPM’s mission is to bring innovative therapeutic and diagnostic solutions to treat therapeutic resistance and metastasis evolution. Source (opens in a new tab)

Website: https://www.oncodesign.com/
Headquarters: FR